Does NIRAPARIB Cause Lymphadenopathy? 201 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 201 reports of Lymphadenopathy have been filed in association with NIRAPARIB (ZEJULA). This represents 0.9% of all adverse event reports for NIRAPARIB.
201
Reports of Lymphadenopathy with NIRAPARIB
0.9%
of all NIRAPARIB reports
3
Deaths
37
Hospitalizations
How Dangerous Is Lymphadenopathy From NIRAPARIB?
Of the 201 reports, 3 (1.5%) resulted in death, 37 (18.4%) required hospitalization, and 13 (6.5%) were considered life-threatening.
Is Lymphadenopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 201 reports have been filed with the FAERS database.
What Other Side Effects Does NIRAPARIB Cause?
Nausea (5,794)
Fatigue (5,240)
Constipation (4,128)
Platelet count decreased (4,102)
Insomnia (2,861)
Blood pressure increased (2,464)
Headache (2,383)
Off label use (2,213)
Vomiting (2,029)
Carbohydrate antigen 125 increased (1,868)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)
Which NIRAPARIB Alternatives Have Lower Lymphadenopathy Risk?
NIRAPARIB vs NIRMATRELVIR\RITONAVIR
NIRAPARIB vs NIROGACESTAT
NIRAPARIB vs NIROGACESTAT HYDROBROMIDE
NIRAPARIB vs NIRSEVIMAB
NIRAPARIB vs NIRSEVIMAB-ALIP